Jazz Pharmaceuticals (JAZZ) Accumulated Expenses (2010 - 2026)
Jazz Pharmaceuticals' Accumulated Expenses was $1.03 billion in Q2 2026, up 17.7% from $874.81 million a year earlier and up 0.7% from the prior quarter.
Powered by 
Analysis
Jazz Pharmaceuticals (JAZZ) Accumulated Expenses (2010 - 2026) Analysis & Trends
From Q4 2010 onward, Jazz Pharmaceuticals has reported Accumulated Expenses for 62 quarters.
- Accumulated Expenses shows a five-year compound annual growth rate of 24.0% (FY2020 to FY2025).
- In earlier years, Accumulated Expenses was $910.95 million in FY2024 (+14.7%), $793.91 million in FY2023 (-1.2%), $803.26 million in FY2022 (+20.6%) and $666.3 million in FY2021 (+88.9%).
- Quarterly Accumulated Expenses has moved between $593.21 million (Q2 2022) and $1.06 billion (Q1 2025) over five years.
- Compared with a year earlier, Accumulated Expenses was higher in seven of the last eight quarters, with growth averaging 13.5%.
- The best year-over-year quarter for Accumulated Expenses over five years was Q3 2021 (growth of 99.9%); the worst was Q1 2026 (a decline of 3.9%).
- Per Business Quant data, JAZZ's Accumulated Expenses in the three quarters before Q2 2026 was $1.02 billion (Q1 2026), $1.03 billion (Q4 2025) and $1 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Jazz Pharmaceuticals | 15.03 Bn | 8.85 Bn | 1.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.03 Bn |
| Mar 31, 2026 | 1.02 Bn |
| Dec 31, 2025 | 1.03 Bn |
| Sep 30, 2025 | 1.00 Bn |
| Jun 30, 2025 | 874.81 Mn |
| Mar 31, 2025 | 1.06 Bn |
| Dec 31, 2024 | 910.95 Mn |
| Sep 30, 2024 | 858.58 Mn |
| Jun 30, 2024 | 800.99 Mn |
| Mar 31, 2024 | 826.53 Mn |
| Dec 31, 2023 | 793.91 Mn |
| Sep 30, 2023 | 769.94 Mn |
| Jun 30, 2023 | 748.30 Mn |
| Mar 31, 2023 | 712.35 Mn |
| Dec 31, 2022 | 803.26 Mn |
| Sep 30, 2022 | 668.39 Mn |
| Jun 30, 2022 | 593.21 Mn |
| Mar 31, 2022 | 604.71 Mn |
| Dec 31, 2021 | 666.30 Mn |
| Sep 30, 2021 | 603.72 Mn |
API Access
Jazz Pharmaceuticals Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=JAZZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "JAZZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=JAZZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();